Cara Therapeutics Inc. sell StockNews.com
Start price
17.02.24
/
50%
€0.54
Target price
17.02.25
-
Performance (%)
-25.51%
End price
18.02.25
-
Summary
This prediction is currently being closed. The prediction for Cara Therapeutics Inc. shows a convincing performance of -25.51%. StockNews_com has a follow-up prediction for Cara Therapeutics Inc. where he still thinks Cara Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cara Therapeutics Inc. | - | - | - |
iShares Core DAX® | 3.109% | -0.124% | 36.052% |
iShares Nasdaq 100 | 3.088% | 4.723% | 20.631% |
iShares Nikkei 225® | 4.760% | 5.051% | 11.016% |
iShares S&P 500 | 1.840% | 3.430% | 13.790% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten